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Abstract
We present the case of a 21 year-old man holidaying on the Spanish island of Mallorca,
a region of high outbreak of infections with a new influenza A/H1N1 virus. Symptomatic
influenza A infection, but not H1N1 positive, led to myocarditis after intimate contact with
a woman with positive H1N1 titer. The electrocardiogram showed T-wave inversions in II, III,
aVF and V5, V6. Serum chemistry showed elevated levels of troponin T, increased creatine
kinase (CK) and CK myocardial band. Cardiac magnetic resonance imaging revealed mid-
-myocardial and subepicardial hyperintensities in the lateral wall, and subepicardial and
mid-myocardial areas of gadolinium enhancement in the inferior wall. Despite intimate con-
tact with an H1N1 positive patient, the analyses on H1N1 (H1 A/Brisbane/59/07, H1 A/
/California/7/09swine) were negative, but were positive for common influenza (H3 A/Brisbane/
/10/07). Myocarditis is a rare clinical manifestation of influenza A infection. (Cardiol J 2011; 18,
4: 441–445)
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Introduction
Myocarditis, an inflammation leading to myo-
cardial cell necrosis, can be caused by various in-
fectious agents such as viruses, bacteria, rickettsia
and spirochaeta, but also drugs, toxins and syste-
mic diseases. Of the causes, viral myocarditis is the
commonest [1]. Frequent pathogens are coxsac-
kievirus and adenovirus, whereas others like influ-
enza A virus are uncommon and rare causes of
myocarditis. The literature describes only a few
cases of influenza A associated myocarditis [2–4].
Influenza A is subdivided into 16 hemaggluti-
nin (H1 to H16) and 9 neuraminidase (N1 to N9)
subtypes. In contrast to seasonal influenza, the
swine-derived subtype H1N1 is highly contagious
and can lead to an outbreak of pandemic H1N1 vi-
rus infection [5]. Until now, H1N1 associated myo-
carditis has not been described. However, because
of the pandemic spread, H1N1 infection must be
considered in the differential diagnosis of influenza
A myocarditis.
The diagnosis of myocarditis is an integrated
synopsis including history, clinical evaluation, elec-
trocardiogram (ECG) pattern, biomarkers and car-
diac magnetic resonance imaging (MRI). MRI is the
primary tool for non-invasive assessment of myo-
carditis, showing subepicardial late enhancement
pattern, thereby visualizing myocarditis-related
necrosis [6].
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Case report
A 21-year old man suffered from an influenza-
-like illness associated with high fever, cephalgia,
dizziness and upper respiratory tract illness while
spending his holidays on the Spanish island of Mal-
lorca, a high outbreak region of infections with
a new influenza A (H1N1) virus. He complained of
intermittent chills and body aches. The history re-
vealed that the patient had had intimate contact with
a woman suffering from H1N1 virus infection. One
week after the influenza-like symptoms, the patient
presented with dyspnea (NYHA-class II), fatigue
and ECG changes in our hospital. Typical angina-
-like chest pain was denied. Clinical examination was
normal for age and chest X-ray was unremarkable.
The ECG showed T-wave inversions in II, III, aVF
and V5, V6 (Fig. 1). Serum chemistry showed elevat-
ed C-reactive protein [20.1 mg/L (ref. < 5 mg/L)]
and elevated levels of troponin T [1.33 µg/L (ref.
< 0.1 µg/L)] and increased lactate dehydrogenase
[419 U/L (ref. 80–248 U/L)]. White blood cell count,
creatine kinase (CK) and CK myocardial band were
normal (Table 1). Transthoracic echocardiography
displayed a slightly reduced left ventricular func-
tion (50%) without pericardial effusion. Microbio-
logical analyses of blood cultures and serologies
were negative for anti-streptolysin, borrelia burg-
dorferi, brucella species, yersinia species, coxsackie
virus, Epstein-Barr virus, echovirus, cytomegalo-
virus, adenovirus, enterovirus and influenza B. Rheu-
matological parameters were also normal. Serum in-
fluenza A testing and polymerase chain reaction
(PCR) for H3 A/Brisbane/10/07 were positive. De-
spite contact with a positive-tested and highly con-
tagious H1N1 virus patient, no H1N1 virus infec-
tion could be proved. PCR and serologies on H1 A/
/Brisbane/59/07, H1 A/California/7/09swine were
negative (Table 2).
The MRI diagnostic showed typical signs of
myocarditis with slightly reduced left ventricular
ejection fraction (LVEF 49%) and small pericardial
effusion. As correlates for myocardial edema, mid-
myocardial and subepicardial hyperintensities, as well
Figure 1. Electrocardiography showing T-wave inversions in II, III, aVF and V5, V6.
Table 1. Blood analysis at admission.
Ref.
Troponin T [µg/L] 1.33 < 0.1
Creatinine kinase (CK) [U/L] 136 15–174
CK myocardial band [U/L] 12 0–23
Lactate dehydrogenase [U/L] 419 80–248
White blood cell [/µL] 8080 4000–9000
C-reactive protein [mg/L] 20.1 < 5.0
Creatinine [µmol/L] 95 45–104
Table 2. Influenza serologies and polymerase
chain reaction (PCR).
HHT-Titer PCR
H1 A/Brisbane/59/07 < 10 Negative
H1 A/California/7/09swine < 10 Negative
H3 A/Brisbane/10/07 180 Positive
B/Florida/4/06 < 10 Negative
B/Malaysia/2506/04 < 10 Negative
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as late gadolinium enhancement, were found in the
inferolateral wall (Figs. 2, 3) in mid-myocardial or sub-
epicardial location. The patient was treated with an-
giotensin converting enzyme inhibitors and anti-
-inflammatory non-steroidal anti-rheumatic drugs. He
was discharged symptom-free after 12 days.
Discussion
Myocarditis is defined as myocardial inflamma-
tion caused by viral, bacterial, protozoal, toxic or
immune reactions and is accompanied by myocel-
lular necrosis. In Europe and the United States, viral
infection is the leading cause of myocarditis. Among
all pathogens, influenza A is uncommon. Only a few
case reports can be found in literature [2–4]. Cur-
rently the swine-derived influenza A subtype H1N1
is causing a worldwide pandemia [7]. Until now,
H1N1 associated myocarditis has not been de-
scribed. Yet, due to its rapid global spread, the
H1N1 myocarditis must now be considered in the
differential diagnosis of acute myocarditis. The dia-
gnosis may be difficult to obtain in the early stages
of the disease. In the present case, typical influen-
za-like symptoms occurred after intimate contact
with an H1N1 positive patient. One week after
symptom onset, myocarditis was diagnosed by MRI,
typical ECG changes and elevated serum biomark-
ers. Echocardiographic changes such as left ventri-
cular dysfunction or pericardial effusion are com-
mon abnormalities during myocarditis, but are not
specific. The ‘gold standard’ for diagnosing myo-
carditis is endomyocardial biopsy combined with
histopathology, immunohistology and molecular
techniques to identify viral genomes. There are
some limitations to be considered, as the sensiti-
vity is limited by potential sampling error and severe
complications such as perforation of the ventricle
or tamponade may occur [8, 9].
Therefore, recommendations restrict endomyo-
cardial biopsy to patients with severe heart failure
[8, 9]. In acute viral myocarditis, the treatment of
myocarditis remains supportive. Treatments with
antiviral agents like oseltamivir have not been
tested in influenza A related myocarditis, and im-
munosuppression has not been shown to be effec-
tive in myocarditis [10]. In the present case, angio-
tensin converting enzyme inhibitors and anti-
-inflammatory non-steroidal anti-rheumatic drugs
were administered, leading to an improvement of
clinical parameters.
The MRI has become the primary tool for non-
-invasive assessment of myocardial inflammation in
patients with suspected myocarditis [6]. As illus-
trated in Figures 1 and 2, typical myocarditis find-
ings in MRI are myocardial edema, myocardial ear-
ly and late gadolinium enhancement, pericardial
effusion and left ventricular dysfunction [11].
Figure 2. A. Cine steady-state free precession image in four-chamber view acquired during end-diastole. Normal left
ventricular volume. Arrows show patchy, mid-myocardial hyperintensities in the lateral wall. Due to the T2 features
of the utilized sequence, these suggest myocardial edema. There was no regional wall motion abnormality in the
cine loop; B. T2-weighted black-blood prepared turbo spin-echo image in four-chamber view. Arrows show patchy,
clearly distinguishable mid-myocardial and subepicardial hyperintensities in the lateral wall as a correlate of myocar-
dial edema.
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Figure 3. A. Three-dimensional inversion-recovery gradient-echo image in three-chamber view acquired ten minutes
after administration of gadolinium contrast (0.2 mmol/kg). Arrows show multiple typical areas of well-delineated
enhancement (‘late Gd enhancement’) of the inferolateral wall in mid-myocardial or subepicardial location as a correla-
te of myocardial edema and/or cell necrosis; B. Three-dimensional inversion-recovery late Gd enhancement image
in two-chamber view ten minutes after gadolinium. Subepicardial and mid-myocardial areas of Gd enhancement in
the inferior wall; C. Three-dimensional inversion-recovery late Gd enhancement image of a mid-ventricular short
axis ten minutes after gadolinium. Typical subepicardial rim (arrow) of Gd enhancement in the inferolateral wall.
A
C
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In our patient, PCR and serologies revealed an
infection with influenza A without evidence for the
highly contagious H1 A/Brisbane/59/07 or H1 A/
/California/7/09swine viruses. The duration of viral
excretion is likely to be similar to seasonal influen-
za in the pandemic influenza A/H1N1. In seasonal
influenza, it lasts generally 3–5 days from onset of
symptoms but may persist for up to seven days and
in rare cases even longer [12]. A recent study found
that children were twice as susceptible to infection
with the new pandemic influenza A/H1N1 virus than
were adults (19–50 years) [13]. Another reason for
the lack of H1N1 virus transmission could be a pre-
existing pandemic H1N1 immune response as de-
scribed in serological analyses of the influenza A/
/H1N1 from the Centers for Disease Control and
Prevention [14].
Conclusions
Influenza A infection is an uncommon cause of
myocarditis. In contrast to seasonal influenza, the
swine-derived subtype H1N1 is highly contagious,
leading to the outbreak of a global pandemia. H1N1
myocarditis must be considered in the differential
diagnostic analyses of influenza A myocarditis. The
incidence of influenza-associated myocarditis might
therefore increase. Yet, to date, H1N1 specific
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myocarditis has not been reported. Whether the
H1N1 subtype is even less cardiotropic than com-
mon types of influenza is not known. Therefore,
signs of myocarditis must be evaluated in clinically
apparent influenza infections. MRI can be useful in
detecting myocardial inflammation.
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